Entero Healthcare Solutions IPO Details
IPO Date	February 9, 2024 to February 13, 2024
Listing Date	February 16, 2024
Face Value	₹10 per share
Issue Price Band	₹1195 to ₹1258 per share
Issue Price Final	₹1258 per share
Lot Size	11 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	1,27,20,044 shares
(aggregating up to ₹1,600.00 Cr)
Fresh Issue	79,52,518 shares
(aggregating up to ₹1,000.31 Cr)
Offer for Sale	47,67,526 shares of ₹10
(aggregating up to ₹599.69 Cr)
Employee Discount	₹119.00
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	3,95,77,705 shares
Share Holding Post Issue	4,75,26,830 shares
Entero Healthcare Solutions IPO Reservation
Entero Healthcare Solutions IPO offers total 1,27,25,244 shares. Out of which 94,91,256 (74.59%) allocated to QIB, 37,96,503 (29.83%) allocated to QIB, 18,98,251 (14.92%) allocated to NII, 12,65,500 (9.94%) allocated to RII and 56,94,753 (44.75%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	94,91,256 (74.59%)	NA
NII (HNI) Shares Offered	18,98,251 (14.92%)	NA
Retail Shares Offered	12,65,500 (9.94%)	1,15,045
Employee Shares Offered	70,237 (0.55%)	NA
Total Shares Offered	1,27,25,244 (100.00%)	
Investor Category Reservations
Application Category	Maximum Bidding Limits	Bidding at Cut-off Price Allowed
Only RII	Up to Rs 2 Lakhs	Yes
Only sNII	Rs 2 Lakhs to Rs 10 Lakhs	No
Only bNII	Rs 10 Lakhs to NII Reservation Portion	No
Only employee		Yes
Employee + RII/NII	
Employee limit: (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
If applying as RII: Upto Rs. 2 lakhs
If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs
Yes for Employee and RII/NII
Entero Healthcare Solutions IPO Anchor Investors Details
Entero Healthcare Solutions IPO raises ₹716.40 crore from anchor investors. Entero Healthcare Solutions IPO Anchor bid date is February 8, 2024. Entero Healthcare Solutions IPO Anchor Investors list

Bid Date	February 8, 2024
Shares Offered	56,94,753
Anchor Portion Size (In Cr.)	716.40
Anchor lock-in period end date for 50% shares (30 Days)	March 15, 2024
Anchor lock-in period end date for remaining shares (90 Days)	May 14, 2024
Entero Healthcare Solutions IPO Timeline (Tentative Schedule)
Entero Healthcare Solutions IPO opens on February 9, 2024, and closes on February 13, 2024.

IPO Open Date	Fri, Feb 9, 2024
IPO Close Date	Tue, Feb 13, 2024
Tentative Allotment	Wed, Feb 14, 2024
Initiation of Refunds	Thu, Feb 15, 2024
Credit of Shares to Demat	Thu, Feb 15, 2024
Tentative Listing Date	Fri, Feb 16, 2024
Cut-off time for UPI mandate confirmation	5 PM on Tue, Feb 13, 2024
Entero Healthcare Solutions IPO Lot Size
Investors can bid for a minimum of 11 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	11	₹13,838
Retail (Max)	14	154	₹1,93,732
S-HNI (Min)	15	165	₹2,07,570
S-HNI (Max)	72	792	₹9,96,336
B-HNI (Min)	73	803	₹10,10,174
Entero Healthcare Solutions IPO Promoter Holding
The promoters of the company are Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited.
Promoter Holding Pre Issue	77.11%
Promoter Holding Post Issue	
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Entero Healthcare Solutions Ltd.
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.

During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.

Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.

The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.

As of 31st March, 2023, the company employs a total of 3014 people in various departments.

Company Financials
Entero Healthcare Solutions Limited Financial Information (Restated Consolidated)
Entero Healthcare Solutions Limited's revenue increased by 30.84% and profit after tax (PAT) rose by 62.28% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	30 Sep 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	1,505.95	1,308.73	1,125.98	833.79
Total Income	1,898.98	3,305.72	2,526.55	1,783.67
Profit After Tax	11.64	-11.10	-29.44	-15.35
Net Worth	660.54	597.66	563.22	487.06
Total Borrowing	488.68	373.52	285.03	141.70
Amount in ₹ Crore
Key Performance Indicator (KPI)
The market capitalization of Entero Healthcare Solutions IPO is ₹3021.21 Cr.

KPI	Values
ROE	-2.66%
ROCE	6.06%
Debt/Equity	0.45
RoNW	-1.86%
Price to Book Value	7.22
Check Entero Healthcare Solutions IPO Peer Comparison here.
Pre IPO	Post IPO
EPS Rs	0.00	9.70
P/E (x)	0	129.75
Note:
The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2023 that is available in RHP.
Objects of the Issue (Entero Healthcare Solutions IPO Objectives)
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

Repayment/prepayment, in full or part, of certain borrowings availed of by the company and its Subsidiaries.
Funding the long term working capital requirements.
Pursuing inorganic growth initiatives through acquisitions.
General corporate purposes.
Entero Healthcare Solutions IPO Review
[Dilip Davda]  The company is one of the leading and fastest growing healthcare product distributor in India. EHSL marked losses for FY21 to FY23 and turned the corner for H1 of FY24. Based on annualized FY24 earnings, the issue appears aggressively priced, discounting all near term positives. Well-informed/risk seeker/cash surplus investors may park funds for the long term reward as it holds prospects going forward. Read detail review...

Entero Healthcare Solutions IPO Subscription Status (Bidding Detail)
The Entero Healthcare Solutions IPO is subscribed 1.53 times on February 13, 2024 6:20:00 PM (Day 3). The public issue subscribed 1.33 times in the retail category, 2.28 times in the QIB category, and 0.22 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	2.28	38,08,069	86,86,172
NII	0.22	19,60,609	4,26,756
    bNII (bids above ₹10L)	0.16	13,07,072	2,13,895
    sNII (bids below ₹10L)	0.33	6,53,537	2,12,861
Retail	1.33	13,07,073	17,43,885
Employee	1.25	74,349	93,071
Total	1.53	71,50,100	1,09,49,884
Total Application : 1,29,800

Entero Healthcare Solutions IPO Prospectus
  ›  Entero Healthcare Solutions IPO DRHP
  ›  Entero Healthcare Solutions IPO RHP
  ›  Anchor Investors in Entero Healthcare Solutions IPO
  ›  Entero Healthcare Solutions IPO Final Prospectus
Entero Healthcare Solutions IPO Listing Details
Listing Date	February 16, 2024
BSE Script Code	544122
NSE Symbol	ENTERO
ISIN	INE010601016
Final Issue Price	₹1258 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹1,258.00	₹1,258.00
Open	₹1,245.00	₹1,228.70
Low	₹1,141.80	₹1,141.00
High	₹1,258.00	₹1,258.00
Last Trade	₹1,149.50	₹1,149.55